Trialogue Plus: Management of cardiovascular risk in hyperglycaemic/ diabetic patients at hospital discharge

Acta Diabetologica

Volumn 50, Issue 6, 2013, Pages 989-998

  Beltramello, Giampietro ^a   Manicardi, Valeria ^b   Mazzuoli, Francesco ^c   Rivellese, Angela ^d  

^a San Bassiano Hospital   (Italy)

^b E Franchini Hospital   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiovascular risk; Diabetes mellitus; Hyperglycaemia; Patients in discharge; Primary and secondary prevention; Recommendations

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EZETIMIBE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; NICOTINIC ACID; PIOGLITAZONE; PLACEBO; PRASUGREL; RESIN; TICAGRELOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MEGADOSE; EDUCATION PROGRAM; GLYCEMIC CONTROL; GOOD CLINICAL PRACTICE; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LOW DRUG DOSE; MEDICAL HISTORY; PATIENT EDUCATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION;

CARDIOVASCULAR DISEASES; CRITICAL PATHWAYS; DIABETES MELLITUS, TYPE 2; HEALTH PLAN IMPLEMENTATION; HUMANS; HYPERGLYCEMIA; ITALY; PATIENT DISCHARGE; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; RISK FACTORS; SECONDARY PREVENTION;

EID: 84890484489     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0508-4     Document Type: Article

References (32)

1. Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471-1478
2. Kosiborod M, Rathore SS, Inzucchi SE et al (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078-3086
3. Kosiborod M, Inzucchi SE, Krumholz HM et al (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117:1018-1027
4. Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778
5. Umpierrez GE, Isaacs SD, Bazargan N et al (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982
6. Inzucchi SE (2006) Management of hyperglycemia in the hospital setting. N Engl J Med 355:1903-1911
7. Kannel WB, McGee DL (1979) Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 59:8-13
8. Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332:73-78
9. Natarajan S, Liao Y, Sinha D et al (2005) Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 165:430-435
10. Boden EW, O'Rourke RA, Teo KK, COURAGE Trial Research Group et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503-1516
11. Kannel WB (2002) The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med 5:27-37
12. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D et al (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569-2619
13. Hamm CW, Bassand JP, Agewall S et al (2011) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999-3054
14. Beltramello GP, Manicardi V, Trevisan R (2012) Trialogue: La gestione dell'iperglicemia in area medica. Istruzioni per l'uso. Acta Diabetol NS1:NS3-NS12
15. Gaede P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393
16. Standard Italiani per la cura del diabete mellito. AMD-SID 2009-2010. http://www.siditalia.it/linee-guida.html
17. Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364-1379
18. Rivellese AA, Piatti PM, Italian Intersociety Consensus Group (2011) Consensus on: screening and therapy of coronary heart disease in diabetic patients. Nutr Metab Cardiovasc Dis 21:757-764
19. Moghissi ES, Korytkowski MT, DiNardo M et al (2009) American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:1119-1131
20. Malmberg K, Ryden L, Efendic S et al (1995) Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26:57-65
21. The ORIGIN Trial Investigators (2012) Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 367:319-328
22. Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney PM, Blackwell L, Collins R et al (2008) Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371:117-125
23. Baigent C, Landray MJ, Reith C et al, SHARP Investigators (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377:2181-2192
24. HPS2-THRIVE Collaborative Group (2013) HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. Eur Heart J 34:1279-1291
25. Hermida RC et al (2011) Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270-1276
26. Parris ES, Lawrence DB, Mohn LA, Long LB (2005) Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 28:595-599
27. Colivicchi F, Abrignani MG, Santini M (2010) Aderenza terapeutica: il fattore di rischio occulto. G Ital Cardiol 11(5 Suppl 3):1245-1275
28. Ho PM, Spertus JA, Masoudi FA et al (2006) Impact of medication therapy discontinuation on mortality in myocardial infarction. Arch Intern Med 166:1842-1847
29. Chaitman BR, Hardison RM, Adler D et al (2009) Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 120:2529-2540
30. BARI 2D Study Group (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360:2503-2515
31. Brooks MM, Chaitman BR, Nesto RW et al (2012) BARI 2D Study Group. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the by-pass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial. Circulation 126:2115-2124
32. Hlatky MA, Boothroyd DB, Bravata DM et al (2009) Coronary artery bypass surgery compared with percutaneous coronary intervention for multivessel disease: a collaborative analysis of individual patient data from ten randomized trials. Lancet 373:1190-1197